Inventor · disambiguated record
Antoni Krasinski
Also filed as: KRASINSKI ANTONI
36 granted patents·7 pending applications·265 citations·filing 2006–2023
97Inventor score
Top patents by PatentIndex Score
43 records- 0199US7884110B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationCHEMOCENTRYX INC·Filed 2008·Granted Feb 8, 2011·41 cites·6 claims
- 0298US9834545B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2016·Granted Dec 5, 2017·26 cites·33 claims
- 0397US9745312B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationCHEMOCENTRYX INC·Filed 2016·Granted Aug 29, 2017·13 cites·19 claims
- 0496US11026935B2Free base crystalline form of a complement component C5a receptorCHEMOCENTRYX INC·Filed 2020·Granted Jun 8, 2021·5 cites·9 claims
- 0596US9394307B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationCHEMOCENTRYX INC·Filed 2013·Granted Jul 19, 2016·15 cites·19 claims
- 0695US8546408B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationKRASINSKI ANTONI·Filed 2010·Granted Oct 1, 2013·23 cites·11 claims
- 0794US10336736B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2017·Granted Jul 2, 2019·6 cites·24 claims
- 0894US10329314B2Soluble C5aR antagonistsCHEMOCENTRYX INC·Filed 2018·Granted Jun 25, 2019·12 cites·21 claims
- 0994US9745268B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Aug 29, 2017·11 cites·31 claims
- 1094US8519135B2Heteroaryl sulfonamides and CCR2/CCR9CHEN WEI·Filed 2009·Granted Aug 27, 2013·29 cites·4 claims
- 1193US10266492B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Apr 23, 2019·8 cites·10 claims
- 1292US9169261B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2013·Granted Oct 27, 2015·13 cites·26 claims
- 1391US11059825B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Jul 13, 2021·2 cites·11 claims
- 1491US10988464B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2019·Granted Apr 27, 2021·3 cites·16 claims
- 1591US8916601B2Aza-aryl 1H-pyrazol-1-YL benzene sulfonamidesCHEMOCENTRYX INC·Filed 2013·Granted Dec 23, 2014·12 cites·20 claims
- 1690US10487098B2Soluble C5aR antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Nov 26, 2019·6 cites·7 claims
- 1789US10532982B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Jan 14, 2020·4 cites·1 claims
- 1889US7557213B2Substituted quinolones and methods of useCHEMOCENTRYX INC·Filed 2006·Granted Jul 7, 2009·18 cites·15 claims
- 1987US10208050B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationCHEMOCENTRYX INC·Filed 2017·Granted Feb 19, 2019·2 cites·18 claims
- 2086US9783544B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Oct 10, 2017·4 cites·26 claims
- 2185US11254695B2Soluble C5aR antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Feb 22, 2022·1 cites·16 claims
- 2285US10596163B2Aza-aryl 1H-pyrazol-1-yl benzene sulfonamidesCHEMOCENTRYX INC·Filed 2018·Granted Mar 24, 2020·3 cites·19 claims
- 2381US10206912B2Heteroaryl sulfonamides and CCR2/CCR9CHEMOCENTRYX INC·Filed 2016·Granted Feb 19, 2019·2 cites·26 claims
- 2480US10137120B2Aza-aryl 1H-pyrazol-1-yl benzene sulfonamidesCHEMOCENTRYX INC·Filed 2014·Granted Nov 27, 2018·2 cites·19 claims
- 2579US11845729B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2022·Granted Dec 19, 2023·0 cites·10 claims
- 2678US11834452B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2021·Granted Dec 5, 2023·0 cites·14 claims
- 2778US10287292B2CXCR7 antagonistsCHEMOCENTRYX INC·Filed 2017·Granted May 14, 2019·1 cites·7 claims
- 2877US2023381167A1FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a RECEPTORCHEMOCENTRYX INC·Filed 2023·Application pending·0 cites
- 2976US2022047575A1Aza-aryl 1h-pyrazol-1-yl benzene sulfonamidesCHEMOCENTRYX INC·Filed 2021·Application pending·0 cites
- 3075US11207294B2Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Dec 28, 2021·1 cites·6 claims
- 3173US11820759B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2021·Granted Nov 21, 2023·0 cites·8 claims
- 3273US11433061B2Heteroaryl sulfonamides and CCR2/CCR9CHEMOCENTRYX INC·Filed 2020·Granted Sep 6, 2022·0 cites·16 claims
- 3372US8293925B2Pyrrolidinone carboxamide derivativesCHARVAT TREVOR T·Filed 2010·Granted Oct 23, 2012·2 cites·15 claims
- 3472US2020354320A1PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTSCHEMOCENTRYX INC·Filed 2019·Application pending·0 cites
- 3571US11684606B2Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2CHEMOCENTRYX INC·Filed 2021·Granted Jun 27, 2023·0 cites·15 claims
- 3670US10899765B2Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammationCHEMOCENTRYX INC·Filed 2019·Granted Jan 26, 2021·0 cites·20 claims
- 3768US2020197386A1Aza-Aryl 1H-Pyrazol-yl Benzene SulfonamidesCHEMOCENTRYX INC·Filed 2020·Application pending·0 cites
- 3868US2022096453A1FREE BASE CRYSTALLINE FORM OF A COMPLEMENT COMPONENT C5a RECEPTORCHEMOCENTRYX INC·Filed 2021·Application pending·0 cites
- 3966US10532044B2Heteroaryl sulfonamides and CCR2/CCR9CHEMOCENTRYX INC·Filed 2019·Granted Jan 14, 2020·0 cites·20 claims
- 4060US12018016B2Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitorsCHEMOCENTRYX INC·Filed 2022·Granted Jun 25, 2024·0 cites·59 claims
- 4157US2017283446A1SOLUBLE C5aR ANTAGONISTSCHEMOCENTRYX INC·Filed 2017·Application pending·0 cites
- 4250US8716494B2Pyrrolidinone carboxamide derivativesCHEMOCENTRYX INC·Filed 2012·Granted May 6, 2014·0 cites·25 claims
- 4345US2007021484A1Substituted N-cinnamyl benzamidesCHEMOCENTRYX INC·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →